Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW274150 for migraine prophylaxis
2005-001335-30Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing GW274150 with Placebo (2 arms). Primary endpoints: Primary efficacy endpoint, Dose-response relationship and 1 more. Started Aug 2005; status: completed.
02
Drugs
GW274150
03
Conditions
migraine
Beyond the preview
Go deeper on 2005-001335-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001335-30.